Insights from proteomic studies on schizophrenia preclinical models: What can we learn for drug discovery?

Lorna A. Farrelly, Melanie Föcking, David R. Cotter

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Insights from proteomic studies on schizophrenia preclinical models: What can we learn for drug discovery?'. Together they form a unique fingerprint.

Medicine & Life Sciences